DANIELS ERIC JOSEPH (Chief Development Officer) received a stock award from KIORA PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/10/2026ACC: 0001372514-26-000014
Officer· Chief Development Officer
Since Oct 2021
+19.60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
19.60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.53K
Price / share
—
Trade value
—
% of position
25.0%
3/6/2026
26.14K→32.67K
Total
Net shares
+6.53K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2026 | A · Award | +6.53K | — | — | 25.0% | 26.14K | 32.67K |
| Total | +6.53K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
13.07K shares
Shares
+13.07K
Strike price
1.98
Held after
13.07K
Exercisable
—
3/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock13.07K shares | 3/6/2026 | A · Award | +13.07K | 1.98 | — | 13.07K |